{
  "drug_name": "saw plamitto",
  "nbk_id": "NBK614172",
  "url": "https://www.ncbi.nlm.nih.gov/books/NBK614172/",
  "scraped_at": "2026-01-11T18:47:53",
  "sections": {
    "indications": "Renal abscesses are a rare but critical complication of urinary tract infections (UTIs) and bacteremia, often arising from inadequately managed pyelonephritis or hematogenous spread of pathogens. These infections present significant challenges, particularly in patients with diabetes, immunosuppression, or anatomical abnormalities of the urinary tract.\n[1]\n[2]\n[3]\nRenal abscesses are localized collections of purulent material within the renal parenchyma or the perinephric space, reflecting a complex interaction between host immune responses and microbial virulence.\n[4]\n[5]\n\nThe kidney comprises a homogeneous outer cortex, a central medulla, calyces, and a pelvis. The medulla contains numerous renal pyramids formed by the convergence of collecting renal tubules that drain into minor calyces. These minor calyces coalesce to form major calyces, which eventually converge to drain into the renal pelvis. Intrarenal urinary reflux primarily affects the upper and lower pole calyces due to their anatomical orientation. This can lead to urinary stasis and infection, potentially resulting in corticomedullary abscess formation.\n[6]\nPlease see StatPearls' companion resource, \"\nVesicoureteral Reflux\n,\" for more information.\n\nThe unique anatomy and physiology of the kidneys make them particularly susceptible to abscess formation. Their highly vascularized structure supports both ascending infections, commonly caused by uropathogenic\nEscherichia coli\n, and hematogenous seeding from pathogens such as\nStaphylococcus aureus\n.\n[7]\n[8]\n[9]\nAnatomically, abscesses usually originate in the corticomedullary region, where bacterial colonization is more likely due to urinary stasis or obstruction. In severe cases, the infection may extend beyond the renal capsule into the perinephric and pararenal spaces, emphasizing the importance of early intervention.\n[10]\n[11]\n[12]\n\nThe natural history of renal abscesses involves a progression from localized nephritis to abscess formation, especially in cases of delayed diagnosis or inadequate treatment.\n[13]\n[14]\nDespite advancements in imaging modalities such as contrast-enhanced computed tomography (CT) and ultrasonography, which allow for precise localization and characterization, these infections frequently pose diagnostic challenges due to their nonspecific clinical presentations.\n[15]\n[16]\n[17]\n\nPatterns of spread vary depending on the etiology. Obstructive uropathy, such as that caused by calculi, promotes localized infection and tissue necrosis, while hematogenous dissemination can lead to multifocal or systemic involvement.\n[18]\n[19]\nComorbidities such as diabetes and chronic renal disease increase susceptibility and complicate management, highlighting the need for a multidisciplinary approach.\n[20]\n[21]\n[22]\n\nRenal abscesses remain a significant clinical concern that requires prompt recognition and tailored management strategies. Successful treatment relies on a combination of accurate imaging, timely antimicrobial therapy, and, when necessary, drainage interventions to reduce complications and improve patient outcomes.\n[8]\n[23]\n[24]",
    "mechanism": "Renal abscesses are caused by bacterial infections that localize within the renal parenchyma or surrounding tissues, typically resulting from ascending UTIs or hematogenous spread from distant sources. The most common pathogens include\nE c\noli\nand\nKlebsiella pneumoniae\n, which are frequently responsible for ascending infections, and\nS aureus\n, which is often implicated in cortical abscesses and hematogenous dissemination.\n[4]\n[7]\n[11]\nOther pathogens, such as\nProteus mirabilis,\nEnterobacter,\nSerratia,\nand occasionally\nCandida\nspecies, are more commonly seen in patient populations with diabetes mellitus or immunosuppression.\n[8]\n[9]\n\nIn the modern era, renal abscesses caused by\nS aureus\nhave become relatively uncommon, except in certain populations, such as intravenous (IV) drug users who may develop staphylococcal endocarditis.\n[25]\nHematogenous spread typically leads to renal cortical abscesses (90%) and can originate from the contralateral kidney or cutaneous staphylococcal infections.\n[26]\nStaphylococcal bacteremia can lead to renal abscesses, which may present as solitary carbuncles or multiple (miliary) abscesses within 8 weeks of the initial infection. However, these presentations are now rare due to the prompt administration of antibiotics for significant\nS aureus\ninfections\nS aureus\ninfections.\n[26]\n[27]\n[28]\n\nAnatomical or functional abnormalities have a significant role in the pathogenesis of renal abscesses. Obstructive uropathies, such as urinary calculi or strictures, promote urinary stasis and bacterial colonization, while conditions such as vesicoureteral reflux lead to retrograde flow, increasing the risk of recurrent infections.\n[13]\n[17]\nAbout 30% of corticomedullary abscesses are associated with urolithiasis.\n[29]\nIn children, congenital urinary tract abnormalities, such as ureteropelvic junction obstructions, vesicoureteral reflux, calyceal diverticula, and urolithiasis, are significant risk factors for renal abscesses.\n[10]\n[30]\n\nComorbid conditions significantly influence the development of renal abscesses. Diabetes mellitus is strongly associated with these infections due to impaired immune function and a hyperglycemic environment that promotes bacterial growth.\n[14]\n[23]\nMore than half of patients with corticomedullary abscesses have diabetes. Immunosuppressive states, such as those caused by malignancy, organ transplantation, or long-term corticosteroid use, further increase susceptibility by weakening the body’s defenses against opportunistic infections.\n[19]\n[20]\n[21]\n\nLess commonly, renal abscesses may arise from the direct extension of infections, such as perinephric abscesses secondary to pyelonephritis or trauma, including iatrogenic causes such as instrumentation during urological procedures. These contribute to approximately two-thirds of patients with corticomedullary renal abscesses.\n[10]\n[15]\n[18]\nThe increasing prevalence of multiple drug–resistant organisms further complicates treatment, particularly in healthcare-associated infections.\n[12]\n\nA splenectomy significantly increases the risk of renal abscess, particularly in patients with diabetes, doubling the likelihood of occurrence.\n[31]\nRare etiologies include fungal infections in immunocompromised patients and tuberculosis, which should be considered in endemic regions or cases of chronic abscess formation.\n[22]\n[24]\nIdentifying specific risk factors is crucial due to the diverse and complex nature of renal abscess etiology.",
    "monitoring": "Evaluating potential renal abscesses requires a structured diagnostic approach that combines clinical assessment, laboratory biomarkers, and early multimodality imaging. While laboratory findings offer supportive diagnostic clues, imaging remains the definitive method for confirming renal abscesses, determining severity, and guiding treatment decisions.\n\nEarly identification of a renal abscess is essential, as delayed diagnosis elevates the risk of sepsis, perinephric extension, further renal damage, increased morbidity and mortality, prolonged hospital stays (often exceeding 22 days), and a greater need for invasive surgical procedures.\n[4]\n\nSeveral factors contribute to diagnostic delays. Many other conditions present with similar nonspecific symptoms, such as fever, flank pain, and gastrointestinal upset, leading to an initial misdiagnosis. Renal abscess is often not considered a potential diagnosis at the time of the initial presentation, resulting in a delay in imaging studies. Additionally, symptoms typically persist for a relatively long period (mean of 20 days) before hospitalization, which may suggest a less severe underlying condition.\n[27]\n\nRenal abscesses are often associated with significantly elevated nonspecific inflammatory markers, such as leukocytosis with neutrophilia, increased C-reactive protein (CRP), and a high erythrocyte sedimentation rate (ESR).\n[9]\nAlthough these markers indicate systemic infection, they lack specificity and should be interpreted in conjunction with clinical findings (fever, flank pain, CVA tenderness, and symptoms of UTI) and imaging results.\n[7]\nThese markers can also be used to track the progress of the infection and assess the patient's response to therapy.\n\nBlood cultures are positive in 40% to 60% of cases, most commonly identifying\nE coli, K pneumoniae,\nand\nS aureus\n.\n[5]\nIn cases of hematogenous spread, blood cultures may be positive even when urine cultures are sterile, highlighting the need for comprehensive systemic microbiological assessment.\n[30]\nConversely, urinalysis and urine cultures may be negative, especially when the abscess results from hematogenous dissemination rather than ascending UTIs.\n[17]\n\nImaging\n\nImaging is the cornerstone of renal abscess diagnosis, as clinical and laboratory findings are often nonspecific and insufficient for a definitive diagnosis.\n\nUltrasonography\n\nUltrasonography, while less sensitive than CT, remains a first-line imaging modality in the emergency room setting, for pregnant patients, and in pediatric populations.\n[20]\nThis also provides real-time evaluation and guidance for percutaneous drainage procedures.\n[20]\nHowever, ultrasonography has limited sensitivity in detecting smaller abscesses or multiloculated collections.\n[18]\n\nAn ultrasound typically reveals a cavity with thickened walls filled with fluid. A common finding is an intrarenal fluid collection showing horizontal separation between an upper fluid level of lower-density material (urine) and a lower level of denser fluid (pus). The abscess may have ill-defined borders and display low-amplitude internal echoes.\n\nAdditional signs may include:\n\nDecreased vascularity on Doppler studies\nDisruption of the corticomedullary junction\nDirty shadowing from gas within the abscess cavity\nInternal echoes from debris and septations\nPosterior acoustic enhancement\n\nDistinguishing sterile fluid collections from purulent material in a renal abscess can be difficult on ultrasound. Additionally, ultrasonographic echoes from necrotic renal debris in an abscess may be challenging to differentiate from central necrosis seen in a renal malignancy.\n\nContrast-Enhanced Computed Tomography\n\nCT is considered the gold standard for diagnosing renal abscesses, with a sensitivity of 92% to 98%.\n[13]\nTypical CT findings include hypodense fluid collections with peripheral rim enhancement, often accompanied by internal septations. In some cases, intralesional gas may be present, indicating infection with gas-forming organisms such as\nE coli\nor\nK pneumoniae\n.\n[22]\n[32]\n[38]\n\nOther possible CT radiographic signs of a renal abscess include:\n[38]\n\nLobar renal necrosis\nParenchymal inflammation\nPerinephric fat edema and/or stranding\nRenal enlargement\nThickening of Gerota fascia\n\nMagnetic Resonance Imaging\n\nMagnetic resonance imaging (MRI) is an alternative imaging modality for renal abscess and lobar nephronia, particularly in pediatric populations, pregnant patients, those seeking to avoid ionizing radiation, and individuals with renal insufficiency (GFR <30 mL/min) or severe contrast allergies. MRI offers superior soft tissue contrast and enhances differentiation from neoplasms or hematomas.\n[12]\n[39]\n[40]\nChronic-phase dimercaptosuccinic acid (DMSA) renal scintigraphy can detect renal scarring but is not otherwise useful for diagnosing renal abscesses or lobar nephronia.\n[41]\n\nLobar nephronia:\nCT imaging may occasionally reveal a poorly defined, round, or wedge-shaped hypodense area with poor enhancement in the kidney after IV contrast injection, referred to as lobar nephronia or acute focal nephritis. Unlike a renal abscess, which can be detected on CT without contrast, lobar nephronia requires IV contrast for identification. This represents an intermediate stage of localized infectious interstitial nephritis, positioned between acute pyelonephritis and renal abscess formation. The diminished contrast enhancement is attributed to localized inflammatory ischemia, with no liquefaction present.\n\nLobar nephronia can rapidly progress to a full-blown renal abscess, often within 3 days or less, particularly in diabetic patients. Since there is no liquefaction, drainage is not typically required, and the condition usually responds well to antibiotic therapy. Once healed, the affected kidney often develops a permanent cortical scar.\n\nLobar nephronia was traditionally considered rare in the pediatric population, but recent evidence indicates it is often underdiagnosed in children.\n[42]\nFever is common, along with markedly elevated inflammatory markers, even in cases with negative urinalyses and blood or urine cultures.\n[42]\nUnexplained abdominal pain and fever in children with significantly elevated inflammatory markers should raise suspicion for pediatric lobar nephronia, even when urinalyses and cultures are negative.\n[42]\n[43]\n\nTreatment typically involves IV or oral antibiotics for 2 to 4 weeks, along with appropriate follow-up imaging and monitoring to ensure eradication of the infection, relief of symptoms, and resolution of the abscess.\n\nEarly imaging is recommended for high-risk patients, including those with diabetes, immunosuppression, or recurrent UTIs, as delayed diagnosis significantly increases the risk of sepsis and renal impairment.\n[30]\nFollow-up imaging is often necessary to monitor treatment response, ensuring that any unresolved abscesses are promptly managed through repeat drainage, escalation of antimicrobial therapy, or surgical intervention if needed.\n[14]",
    "administration": "Managing renal abscesses requires a multidisciplinary approach due to the significant variability in etiology, severity, and complications. Early collaboration among urologists, infectious disease specialists, interventional radiologists, nephrologists, critical care physicians, and allied health professionals is crucial for optimizing patient outcomes.\n[4]\n[30]\n\nAbscess size significantly influences management decisions. Abscesses (≥5 cm) typically require percutaneous drainage due to poor antibiotic penetration, an increased risk of spontaneous rupture, and prolonged infection duration. In contrast, small abscesses (<3 cm, and possibly up to 5 cm) in stable patients without systemic symptoms may be managed conservatively with IV antibiotics alone.\n[44]\n\nPercutaneous drainage under CT or ultrasound guidance is the preferred intervention, offering high success rates while minimizing morbidity compared to open surgical drainage.\n[21]\nHowever, in cases where drainage fails, or the abscess is multiloculated, surgical intervention may be necessary, with nephrectomy reserved for cases involving extensive renal parenchymal destruction.\n[24]\nIndividualized treatment strategies should be based on abscess size, anatomical location, and patient-specific factors to eradicate infections, preserve renal function, and prevent systemic complications such as sepsis and multiple organ failure.\n[9]\n\nAntimicrobial Therapy\n\nEmpirical antimicrobial selection:\nPrompt initiation of empirical broad-spectrum IV antibiotics is essential, especially for patients with systemic inflammatory response syndrome (SIRS), bacteremia, or hemodynamic instability.\n[2]\nThe initial choice of antibiotics should be guided by several factors, including:\n\nCommunity-acquired versus healthcare-associated infections\nPatient comorbidities (such as diabetes, immunosuppression, or renal failure)\nLocal resistance patterns\n\nFirst-line empirical regimens:\nEmpirical treatment typically involves a combination of the agents mentioned below.\n\nVancomycin or linezolid: This is recommended in cases where methicillin-resistant\nS aureus\n(MRSA) is suspected or cannot be ruled out.\nPlus, one of the below-mentioned agents for broad-spectrum coverage.\nThird- or fourth-generation cephalosporins (eg, ceftriaxone or cefepime): They provide broad coverage against gram-negative and gram-positive organisms.\nPiperacillin-tazobactam combination: This antibiotic provides additional coverage against anaerobes and extended-spectrum beta-lactamase (ESBL)–producing organisms.\nCarbapenems (such as meropenem and imipenem-cilastatin): These are preferred agents for patients with multiple drug-resistant (MDR) infections, prior healthcare exposures, or ESBL-producing organisms.\nFluoroquinolones: Fluoroquinolone may be added in cases of septic shock and/or more severe illness in combination with one of the above regimens.\n[3]\n[12]\n[14]\n[45]\n\nTargeted Therapy and Duration\n\nOnce microbiological culture and susceptibility results are available, antibiotics should be adjusted to target the specific pathogen, minimizing unnecessary broad-spectrum exposure and reducing the risk of resistance development.\n\nUncomplicated cases typically require initial IV antibiotic therapy, which can transition to oral antibiotics once clinical stability is achieved.\nThe recommended duration of antibiotic therapy is generally 4 weeks, although a minimum of 2 weeks is required.\nDiabetic, immunocompromised, or bacteremic patients may need 6 to 8 weeks of therapy due to the increased risk of treatment failure and recurrence.\nMultifocal abscesses or persistent infection despite adequate drainage may necessitate prolonged courses of IV therapy or even surgical intervention.\n[18]\n[19]\n[46]\n[47]\n\nInfectious disease specialists and antimicrobial stewardship pharmacists are crucial in optimizing antibiotic selection, dosing, duration, and de-escalation strategies, especially for patients with renal impairment.\n[17]\n\nDrainage Procedures\n\nIndications for drainage:\nWhile small renal abscesses (<3 cm) will resolve with antibiotics alone, larger abscesses (>5 cm), multiloculated lesions, or cases with systemic toxicity require drainage.\n[23]\nDrainage of medium-sized renal abscesses (between 3 and 5 cm) is controversial, as both medical and surgical drainage have been effective in these cases.\n[48]\n[49]\n[50]\n\nMedical therapy without diagnostic drainage can lead to unnecessary prolongation of antimicrobial therapy due to the lack of knowledge about the infecting organism and its specific antibiotic sensitivities.\n[48]\nHowever, medical therapy alone may be appropriate in cases where percutaneous procedures pose an elevated risk than normal. Percutaneous drainage procedures are effective in treating medium-sized abscesses and carry a low risk of complications.\n[51]\nHowever, potential but rare complications include bacteremia, gastrointestinal fistula formation, hemorrhage, and pyopneumothorax, which can be avoided with a purely medical approach.\n[48]\n[49]\n\nThe preferred drainage approach depends on the abscess size, location, and the patient's response to initial therapy. Medium-sized abscesses that do not respond to medical therapy alone should be considered for percutaneous drainage. Treatment should be individualized based on clinical presentation.\n\nPercutaneous image-guided drainage: The first-line intervention for abscesses (≥5 cm) and medium-sized abscesses (between 3 and 5 cm) with perinephric extension or severe systemic involvement.\n[13]\n[24]\nEndoscopic or retrograde ureteroscopic drainage: This is recommended for abscesses that communicate with the collecting system or are associated with ureteral obstruction.\n[22]\nSurgical drainage or nephrectomy: These procedures are reserved for cases where percutaneous drainage has failed, extensive renal parenchymal destruction is present, progressive infection persists despite percutaneous catheter drainage, or obstructive uropathy requires correction.\n[20]\n\nPlease see StatPearls' companion resource, \"\nComplicated Urinary Tract Infections\n,\" for more information.\n\nPercutaneous catheter drainage:\nCT or ultrasound-guided percutaneous drainage is the gold standard for liquefied and accessible abscesses.\n[1]\nThe advantages of percutaneous drainage include:\n\nMinimally invasive nature, which reduces morbidity compared to open surgery.\nHigh success rate (>80%) in cases where the abscess is well-localized and drainable.\nAbility to obtain culture specimens for targeted antimicrobial therapy.\n\nPost-procedural care should involve interventional radiologists, nephrologists, urologists, and intensivists, particularly in critically ill patients requiring continuous renal replacement therapy.\n[52]\n\nSurgical Intervention and Nephrectomy Considerations\n\nIndications for surgical intervention include:\n\nComplex, multiloculated abscesses that do not fully drain percutaneously.\nPersistent infection despite adequate antibiotic therapy and percutaneous drainage.\nRenal calculi or anatomical abnormalities causing obstruction, which require simultaneous correction.\nMalignancy or renal abscesses that are associated with necrotic renal cell carcinoma (RCC) and require radical nephrectomy.\n[15]\n[53]\n\nAlthough nephrectomy is typically avoided in active infections, it may be required in cases of irreversible renal destruction, clinical deterioration, or failed conservative therapy.\n[10]\n[15]\n[53]\n\nSupportive and Adjunctive Care\n\nHemodynamic support and critical care:\nIn patients with sepsis or septic shock, resuscitation strategies should include:\n\nAggressive IV fluid resuscitation to maintain renal perfusion.\nVasopressor therapy in cases of refractory hypotension, guided by critical care specialists.\nEarly nephrology consultations for patients at risk of acute kidney injury (AKI) who may require renal replacement therapy.\n[7]\n[11]\n\nPain management strategies:\nRenal abscesses often cause significant flank pain, requiring multimodal analgesia that balances efficacy with renal safety.\n\nAcetaminophen (first-line treatment): This drug is preferred in patients with renal dysfunction.\nNonsteroidal anti-inflammatory drugs: NSAIDs should be used cautiously in patients with impaired renal function due to the risk of AKI.\nOpioids (reserved for severe pain): Short courses may be used but should be tapered early to prevent opioid adverse effects and prevent dependence.\n[5]\n[16]\n\nComorbidities and Special Considerations\n\nPatients with significant comorbidities require specialized management and collaboration among multiple specialties.\n[21]\n\nDiabetes mellitus: Endocrinologists should optimize glycemic control, as poor glucose control correlates with higher infection severity and recurrence risk.\nImmunocompromised patients: Transplant specialists and oncologists should be involved in managing renal abscesses in solid organ transplant recipients, patients receiving chemotherapy, or individuals taking chronic corticosteroids.\nObstructive uropathy: Urologists should initially manage and evaluate concurrent urinary obstruction, which may potentially require interventions such as ureteral stenting, ureteroscopy, or percutaneous nephrostomy placement.\n[5]\n[52]",
    "adverse_effects": "Renal abscesses, although uncommon, carry significant morbidity and mortality risks, particularly in cases of delayed diagnosis, inadequate treatment, or underlying immunosuppression.\n[2]\n[5]\n[11]\nComplications range from localized progression to life-threatening systemic involvement. While perinephric abscess formation and sepsis are relatively common sequelae, fistula formation, rupture, and distant septic embolization, though less frequent, carry serious prognostic implications.\n[9]\n[12]\nUnderstanding the underlying mechanisms, risk factors, and optimal management strategies is essential to preventing progression to chronic renal dysfunction or systemic deterioration.\n\nSepsis and Hematogenous Dissemination\n\nSepsis is one of the most severe complications of renal abscesses, occurring in up to 25% to 50% of cases, with mortality rates approaching 30% in critically ill patients.\n[52]\n[58]\nBacteremia, commonly caused by\nE coli\nand\nK pneumoniae\n, facilitates the hematogenous spread of infection, leading to septic emboli in distant organs such as the lungs, brain, and skin.\n[3]\n[10]\n[13]\nSeptic pulmonary emboli, characterized by multiple cavitary lung lesions on imaging, are a recognized consequence and occur in up to 10% of cases.\n[45]\nAlthough craniofacial necrotizing fasciitis secondary to renal abscess embolization is exceedingly rare, it has been reported in case series, underscoring the potential for catastrophic soft tissue destruction, especially in immunocompromised individuals.\n[16]\n[21]\n\nPerinephric Abscess and Rupture\n\nInfection extending beyond the renal capsule can lead to the formation of a perinephric abscess, a complication seen in 10% to 40% of cases, particularly in patients with delayed presentation, diabetes, or obstructive uropathy.\n[16]\n[18]\nPerinephric abscesses are more challenging to manage than intrarenal abscesses and often require image-guided percutaneous drainage. However, with failure rates of up to 30%, open surgical intervention may be necessary.\n[14]\n\nIn rare cases, a renal abscess may spontaneously rupture into the peritoneal cavity, resulting in pyoperitoneum and peritonitis, which can lead to hemodynamic instability and require emergent laparotomy.\n[22]\n[23]\nRupture into the retroperitoneal space can cause progressive infection and soft tissue destruction, complicating drainage and necessitating aggressive debridement.\n[15]\n\nFistula Formation and Chronic Suppuration\n\nFistulization is an uncommon but debilitating complication of renal abscesses, with nephrocolic, reno-duodenal, and cutaneonephrobronchial fistulas documented in the medical literature.\n[17]\n[46]\n[53]\nNephrocolic fistulas often present with fecaluria and recurrent UTIs, whereas renoduodenal fistulas manifest with chronic nausea, weight loss, and gastrointestinal bleeding.\n[3]\n[13]\nThe rare cutaneonephrobronchial fistula, often associated with prolonged untreated perinephric abscesses, results in persistent respiratory infections and requires definitive surgical correction.\n[69]\n\nRenal Dysfunction and Long-Term Sequelae\n\nPersistent infection, parenchymal destruction, and fibrosis contribute to CKD in 15% to 20% of patients with large or bilateral abscesses.\n[4]\n[12]\nIn severe cases, particularly those complicated by XGP, radical nephrectomy may become the only viable treatment option.\n[18]\n[70]\nAlthough progression to end-stage renal disease is rare, it remains a risk for patients with extensive renal involvement, recurrent abscess formation, or diabetes mellitus.\n[19]\n[45]\n\nMultiple Drug–Resistant Infections and Treatment Failure\n\nThe emergence of ESBL-producing and carbapenem-resistant organisms complicates the management of renal abscesses, leading to treatment failure and prolonged hospitalizations.\n[17]\n[45]\nIn these cases, tailored antibiotic regimens based on local resistance patterns are essential, and early intervention with percutaneous or surgical drainage may be required for refractory cases.\n[30]\nMultidisciplinary collaboration among healthcare teams is crucial to prevent progression to chronic renal dysfunction and systemic complications.\n[46]\n[71]"
  }
}